facebook tracking

Free Patient Webinar

Know What Your Doctors Know: Multiple Myeloma

Two chances to attend!

  • Monday, April 15, 2019 | 5:00 – 6:15 PM ET

  • Tuesday, April 16, 2019 | 10:00 – 11:15 AM ET

Join experts as they discuss treatment of multiple myeloma. This webinar is designed to help participants:

  • Demonstrate an understanding of what multiple myeloma is, and how it is diagnosed and staged
  • Compare, discuss, and select treatment options with their doctor
  • Discover the most recent advancements in multiple myeloma care
  • Identify and utilize supportive care and patient and caregiver resources

Each webinar will also include a Question & Answer session. You may submit questions to the presenters during the webinar or in advance. Register for more details.


  • Introduction
  • Expert Discussion of Multiple Myeloma
  • Question & Answer Session

Click here for a printer-friendly flyer.


  • Shaji K. Kumar, MD
    Professor of Medicine, Mayo Clinic College of Medicine
    Consultant, Division of Hematology
    Medical Director, Cancer Clinical Research Office
    Mayo Clinic
  • Kimberly S. Young, RN
    Registered Nurse
    Mayo Clinic Cancer Center
  • Mary E. DeRome, MSc
    Director, Medical Communications and Education
    Multiple Myeloma Research Foundation

Intended Audience

This event is designed for people with multiple myeloma, their caregivers, and their families.

Please note: This is a non-accredited activity.

Fee Information

Webinars are free to attend. Also, a free copy of the NCCN Guidelines for Patients®: Multiple Myeloma, Version 2019 will be sent to the first 200 registrants to request a book. The NCCN Guidelines for Patients are a patient-friendly version of the NCCN Clinical Practice Guidelines in Oncology. They are a good starting point to learn the best health care options for a type of cancer.


This activity is supported through the NCCN Foundation, by a contribution from our industry supporter Amgen. NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein.

The NCCN Guidelines for Patients: Multiple Myeloma are endorsed by:

The Leukemia & Lymphoma Society (LLS)
Multiple Myeloma Research Foundation (MMRF)
Blood & Marrow Transplant Information Network (BMT InfoNet)
National Bone Marrow Transplant Link (nbmtLINK)